From: "Jonathan Ford" Newsgroups: japan.anime.evangelion References: <3e0c3c65_4@corp.newsgroups.com> Subject: Re: Possiblity of Eva Date: Fri, 27 Dec 2002 19:29:54 +0100 Lines: 147 X-Priority: 3 X-MSMail-Priority: Normal X-Newsreader: Microsoft Outlook Express 6.00.2800.1106 X-MimeOLE: Produced By Microsoft MimeOLE V6.00.2800.1106 NNTP-Posting-Host: 62.122.6.184 Message-ID: <3e0c9c07_1@corp.newsgroups.com> X-Trace: corp.newsgroups.com 1041013767 62.122.6.184 (27 Dec 2002 12:29:27 -0600) X-Comments: This message was posted through Newsfeeds.com X-Comments2: IMPORTANT: Newsfeeds.com does not condone, nor support, spam or any illegal or copyrighted postings. X-Comments3: IMPORTANT: Under NO circumstances will postings containing illegal or copyrighted material through this service be tolerated!! X-Report: Please report illegal or inappropriate use to X-Abuse-Info: Please be sure to forward a copy of ALL headers, INCLUDING the body (DO NOT SEND ATTACHMENTS) Organization: Newsfeeds.com http://www.newsfeeds.com 80,000+ UNCENSORED Newsgroups. Path: ccsf.homeunix.org!ccsf.homeunix.org!news1.wakwak.com!nf2.xephion.ne.jp!feed2.sphere.ad.jp!feed1.sphere.ad.jp!giga-nspixp2!newsfeed.media.kyoto-u.ac.jp!local-out2.newsfeeds.com!corp.newsgroups.com!not-for-mail Xref: ccsf.homeunix.org japan.anime.evangelion:3401 Here's a review of the liquid: Liquivent", it's commercial name, is manufactured by a Biotech Company in San Diego. As well as carrying oxygen, liquivent has a gentle therapeutic effect on the lungs, unlike air forced in at high pressure. The liquid fills the many tiny collapsed air sacs of the patient's lungs, providing the basis for the vital exchange of oxygen into the blood. Due to it's density (it is twice as dense as water) and it's capacity to carry 25 items as much oxygen than water, it can oxygenate the blood long enough to give damaged lungs the necessary time to heal. It has enormous potential for many patients with lung and breathing disorders including infants with very low birth weight and respiratory distress syndrome. It has also been used on patients who have been close to drowning, and may even by used in the future on lung cancer patients. The drug is currently being tested in approximately 55 paediatric centres throughout America. The procedure hasn't been performed in Australia yet, but as the evidence grows in support of its life saving capabilities, it won't be long before we hear about the first case at home. Development of Liquid Ventilation Techniques History The first reported "liquid breathing" experiments in the 1960's heralded the promise of an alternative method for supporting distressed lungs. Researchers found that mice could survive several hours with their lungs filled with an oxygenated saline solution; subsequent use of oxygenated silicone oils met with some success, but these fluids were ultimately found to be toxic. The most significant finding of this period was the potential for use of perfluorochemical (PFC) liquids. These liquids are clear, colorless, odorless, nonconducting, and nonflammable; they are approximately twice as dense as water, and are capable of dissolving large amounts of physiologically important gases (oxygen and carbon dioxide). PFCs are generally very chemically stable compounds, remaining unmetabolized (unchanged) in body tissues. The first physiological tests of PFCs demonstrated that mice and rats submersed in oxygenated PFC fluids could survive for prolonged periods. These findings led to extensive lung physiology studies of liquid breathing using "tidal" or "total" liquid ventilation. This technique involves the complete filling of the lungs with a PFC and, by use of a special liquid ventilator machine, recirculation of the PFC between the patient's lungs and various mechanical components that perform gas exchange, filtration and temperature control. The first clinical feasibility study of tidal liquid ventilation in compassionate treatments of several premature babies was performed in 1989. While these studies demonstrated improvement in the patients' lung compliance and gas exchange, further clinical studies were not pursued due to the lack of a clinically applicable liquid ventilator system and a pharmaceutical-grade PFC. Breakthrough -- "Partial Liquid Ventilation" A breakthrough occurred in 1991, when it was discovered that liquid ventilation could be performed effectively in normal pigs without the use of a liquid ventilator. Sustained, highly efficient gas exchange was achieved by simply filling the lung with a PFC to a prescribed level, and then reconnecting the conventional gas ventilator. This discovery, along with expanded studies sponsored by Alliance Pharmaceutical Corp., established the feasibility of a simplified, practical method of liquid ventilation that could lead to clinical applications. The PLV technique has now been shown to produce significant improvements in lung function and viability in numerous animal studies of diseased or injured lungs. By opening closed alveoli and keeping them open with lower ventilator pressures and reduced oxygen settings, and by increasing the flow of blood to the more open portions of the lung, selected PFCs can apparently minimize lung damage and enable earlier cessation of ventilator therapy. Availability of Medical-Grade PFC Development of PLV therapy for human use was accelerated by the use of LiquiVent® (sterile perflubron). Perflubron (perfluorooctyl bromide), a pharmaceutical-grade PFC, is the most appropriate PFC for medical use among those evaluated to date, due to its combination of high purity, low surface tension, high gas solubility, moderately low vapor pressure, superior spreading characteristics, and demonstrated lack of toxicity. Perflubron has been approved for marketing by the U.S. Food and Drug Administration as an agent for enhancement of magnetic resonance images of the gastrointestinal tract. This unique compound is also used in a perflubron-based emulsion, OxygentT, which is being evaluated in clinical trials as an intravenous oxygen carrier designed to protect tissues from hypoxia (oxygen deficiency) during surgery and other periods of acute oxygen deficit. "Jonathan Ford" wrote in message news:3e0c3c65_4@corp.newsgroups.com... > First of all, we have to cinsider the body of the bio-mech. > > All EVA's are clones of either Lilith or ADAM. As of now we don't have the > capability to genetically engineer such a being, but it may be possible > (since in one episode they say that Angels' DNA is very similar to Human > DNA). As for stabilization, ti won't be a big problem, since and EVA seems > to have a similar skeletal structure to that of a human, with the A-10 link, > the pilot of the EVA will feel, and "be" the mech. Thus the pilot will > automatically correct the balance of an EVA with his mind, just like we all > do when we walk. > > A-10 link: > > We're getting close to that, Scientists are mapping areas of the brain that > control different parts of our bodies, thus giving us the possibiltiy to > control a prosthesis directly from our brain. This has allready been tried > out on a monkey and all the tests came out reasonably well. So a complete > neural interface may be possible in the near future. > > LCL fluid: > > As for breathability, we allready have a similar fluid that's in use. Clear > like water, it has the capability of containing large amounts of oxygen > within it's self, allowing any animals (and humans) to breath normally in > it. When exiting the liquid, it will automatically evaporate from our lungs > rather quickly, allowing us to return to our normal breathing patterns. As > for separating the soul of a person inside of it from his/her body, that is > highly improbable. We don't even know what is counsciousness, Where it > resides in the brain, or if it can be removed. The possibility of moving a > soul from body to body, or even containing it will be a huge ethical > question when it comes up, probably only Hindu's and Buddists' will be very > interested in this question, since they believe in reincarnation. > > "DigitalX" wrote in message > news:k8NO9.172300$Qr.4289706@news3.calgary.shaw.ca... > > is it theoreticly possible to create an Evangelion? > > --- > > -DigitalX > > My sig is always different, and always has one or more spelling erorr > > and/or typo. can you find it? > > --- > > > > > > > > > -----= Posted via Newsfeeds.Com, Uncensored Usenet News =----- > http://www.newsfeeds.com - The #1 Newsgroup Service in the World! > -----== Over 80,000 Newsgroups - 16 Different Servers! =----- -----= Posted via Newsfeeds.Com, Uncensored Usenet News =----- http://www.newsfeeds.com - The #1 Newsgroup Service in the World! -----== Over 80,000 Newsgroups - 16 Different Servers! =-----